roundhill glp 1 & weight loss etf π£LAUNCHING TOMORROW GLP-1 $OZEM Roundhill Investments | LinkedIn
Description
All participants initiated a weight management program involving either semaglutide or tirzepatide
After 56 weeks: Placebo group lost 1.2% of body weight Recommended dose (7.5/46 mg) group lost 7.8% of body weight Top dose (15/92 mg) group lost 9.8% of body weight The EQUIP trial enrolled 1,267 adults with class II and III obesity (BMI 35+)
The only other agent on the market that affects levels of GLP-1 is exen atide (Byetta)
Saller CF, Stricker EM
"So when companies file these types of actions,
Glucagon increases blood glucose levels, particularly during fasting, and facilitates the mobilization of energy reserves
